Not many stocks are likely to double. Even well-run companies like Cisco Systems (NASDAQ:CSCO) are not likely to move 2x even with great results. The market caps are already too large and…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness in the stent market. Stranger than fiction. According to MarketWatch, Abbott says…
Looking around the wreckage of some of the big cap companies it is not hard to find a few CEOs who probably need to go back to business school. Wall St. would…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX) and Johnson & Johnson (JNJ). Stents are small mess implants which are…
Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent studies show that the devices are more dangerous than most doctors had…
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t show financials because we’ve already shown that individually. Here are some of…
Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue for those products at Boston Scientific (BSX) and Johnson & Johnson (JNJ).…
According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid for Rio Tinto (RTP). Reuters writes that most of the Hershey (HSY)…
Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson. It now has long-term debt of almost $8.3 billion. Troubles in its…
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up in South Florida. Still, restoring luster to the popular deviceis likely to…
(AMD) Advanced Micro Devices -$0.71 EPS vs -$0.62 est.(BSX) Boston Scientific $0.20 EPS vs $0.07 guidance.(CAT) Caterpillar $1.40 EPS vs $1.43 est.; narrows 2007 guidance.(FITB) Fifth Third $0.71 EPS vs $0.68 est.(GOOG)…
The stent business continues to dog Boston Scientific (BSX) numbers. Several studies have shown that the devices can cause blood clots. BSX sales for the third quarter of 2007 were $2.048 billion…
Douglas A. McIntyre Accoriding to Reuters, Sony (SNE) will launch a cheaper version of its PS3 in the US in hopes of taking market share from Microsoft (MSFT) and Nintendo. Reuters writes that British Air…
Workers in industries that are not doing well usually get laid off. But, it is not a good omen when workers in robust sectors of the economy are losing their jobs. Countrywide…
